Literature DB >> 28993456

Phosphatidylinositol 4,5-Bisphosphate-Dependent Oligomerization of the Pseudomonas aeruginosa Cytotoxin ExoU.

Angelica Zhang1, Jeffrey L Veesenmeyer1, Alan R Hauser2,3.   

Abstract

The Pseudomonas aeruginosa type III secretion system delivers effector proteins directly into target cells, allowing the bacterium to modulate host cell functions. ExoU is the most cytotoxic of the known effector proteins and has been associated with more severe infections in humans. ExoU is a patatin-like A2 phospholipase requiring the cellular host factors phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] and ubiquitin for its activation in vitro We demonstrated that PI(4,5)P2 also induces the oligomerization of ExoU and that this PI(4,5)P2-mediated oligomerization does not require ubiquitin. Single amino acid substitutions in the C-terminal membrane localization domain of ExoU reduced both its activity and its ability to form higher-order complexes in transfected cells and in vitro Combining inactive truncated ExoU proteins partially restored phospholipase activity and cytotoxicity, indicating that ExoU oligomerization may have functional significance. Our results indicate that PI(4,5)P2 induces the oligomerization of ExoU, which may be a mechanism by which this coactivator enhances the phospholipase activity of ExoU.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  ExoU; Pseudomonas aeruginosa; oligomerization

Mesh:

Substances:

Year:  2017        PMID: 28993456      PMCID: PMC5736810          DOI: 10.1128/IAI.00402-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Membrane Binding of the Rous Sarcoma Virus Gag Protein Is Cooperative and Dependent on the Spacer Peptide Assembly Domain.

Authors:  Robert A Dick; Marilia Barros; Danni Jin; Mathias Lösche; Volker M Vogt
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

2.  Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.

Authors:  A R Hauser; J N Engel
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping.

Authors:  H K Paudel; W Li
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

4.  Structural insight into the activation mechanism of human pancreatic prophospholipase A2.

Authors:  Wei Xu; Lina Yi; Yumei Feng; Ling Chen; Jinsong Liu
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

5.  Analysis of the initiating events in HIV-1 particle assembly and genome packaging.

Authors:  Sebla B Kutluay; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2010-11-18       Impact factor: 6.823

6.  Prevalence of antibiotic resistance in US hospitals.

Authors:  John Edelsberg; Derek Weycker; Rich Barron; Xiaoyan Li; Hongsheng Wu; Gerry Oster; Sejal Badre; Wendy J Langeberg; David J Weber
Journal:  Diagn Microbiol Infect Dis       Date:  2013-11-15       Impact factor: 2.803

7.  Crystal structures of an acidic phospholipase A(2) from the venom of Naja Kaouthia.

Authors:  Lichuan Gu; Zhiqing Wang; Shiying Song; Yuyan Shu; Zhengjiong Lin
Journal:  Toxicon       Date:  2002-07       Impact factor: 3.033

8.  Regulation of vinculin binding to talin and actin by phosphatidyl-inositol-4-5-bisphosphate.

Authors:  A P Gilmore; K Burridge
Journal:  Nature       Date:  1996-06-06       Impact factor: 49.962

9.  A novel phosphatidylinositol 4,5-bisphosphate binding domain mediates plasma membrane localization of ExoU and other patatin-like phospholipases.

Authors:  Gregory H Tyson; Andrei S Halavaty; Hyunjin Kim; Brett Geissler; Mallory Agard; Karla J Satchell; Wonhwa Cho; Wayne F Anderson; Alan R Hauser
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.486

10.  Live-cell observation of cytosolic HIV-1 assembly onset reveals RNA-interacting Gag oligomers.

Authors:  Jelle Hendrix; Viola Baumgärtel; Waldemar Schrimpf; Sergey Ivanchenko; Michelle A Digman; Enrico Gratton; Hans-Georg Kräusslich; Barbara Müller; Don C Lamb
Journal:  J Cell Biol       Date:  2015-08-17       Impact factor: 10.539

View more
  5 in total

Review 1.  Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance.

Authors:  Chongbing Liao; Xin Huang; Qingxia Wang; Dan Yao; Wuyuan Lu
Journal:  Front Cell Infect Microbiol       Date:  2022-07-06       Impact factor: 6.073

Review 2.  Role of Host and Bacterial Lipids in Pseudomonas aeruginosa Respiratory Infections.

Authors:  Pamella Constantino-Teles; Albane Jouault; Lhousseine Touqui; Alessandra Mattos Saliba
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

3.  A pipeline to evaluate inhibitors of the Pseudomonas aeruginosa exotoxin U.

Authors:  Daniel M Foulkes; Keri McLean; Yalin Zheng; Joscelyn Sarsby; Atikah S Haneef; David G Fernig; Craig Winstanley; Neil Berry; Stephen B Kaye
Journal:  Biochem J       Date:  2021-02-12       Impact factor: 3.857

Review 4.  Pseudomonas aeruginosa Toxin ExoU as a Therapeutic Target in the Treatment of Bacterial Infections.

Authors:  Daniel M Foulkes; Keri McLean; Atikah S Haneef; David G Fernig; Craig Winstanley; Neil Berry; Stephen B Kaye
Journal:  Microorganisms       Date:  2019-12-16

Review 5.  Perspectives on the Pseudomonas aeruginosa Type III Secretion System Effector ExoU and Its Subversion of the Host Innate Immune Response to Infection.

Authors:  Kierra S Hardy; Maxx H Tessmer; Dara W Frank; Jonathon P Audia
Journal:  Toxins (Basel)       Date:  2021-12-09       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.